Literature DB >> 15380533

Leishmania infantum enhances human immunodeficiency virus type-1 replication in primary human macrophages through a complex cytokine network.

Chenqi Zhao1, Barbara Papadopoulou, Michel J Tremblay.   

Abstract

Leishmaniasis has emerged as an important potential opportunistic disease among patients infected with human immunodeficiency virus type-1 (HIV-1). It has been reported that the visceral form of leishmaniasis accelerates the course of HIV-1 disease progression and shortens the life expectancy of persons in areas where both diseases are endemic. As both pathogens can infect in a productive manner the same target cell, that is, the macrophage, we examined the possible modulatory effect of the protozoan parasite Leishmania infantum on the biology of HIV-1 in primary human monocyte-derived macrophages (MDMs). We found that coinfection of MDMs with Leishmania and HIV-1 resulted in a significant enhancement of both virus transcription and release of progeny virus. The Leishmania-directed increase in HIV-1 production was associated with an increased secretion of the proinflammatory cytokines TNF-alpha and IL-1 alpha. Altogether, these findings indicate that the presence of Leishmania and HIV-1 within the same cellular microenvironment leads to an enhancement of virus gene expression. The present work also underscores the importance of studying the possible complex interactions between two human pathogens in a physiological cellular reservoir.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15380533     DOI: 10.1016/j.clim.2004.06.003

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  16 in total

1.  High levels of CD4⁺ CTLA-4⁺ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis.

Authors:  A Vallejo; M Abad-Fernández; S Moreno; A Moreno; M J Pérez-Elías; F Dronda; J L Casado
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-21       Impact factor: 3.267

2.  A study of haematological and bone marrow changes in symptomatic patients with human immune deficiency virus infection with special mention of functional iron deficiency, anaemia of critically ill and haemophagocytic lymphohistiocytosis.

Authors:  Jyoti Kotwal; Vikram Singh; Anupam Kotwal; Vibha Dutta; Velu Nair
Journal:  Med J Armed Forces India       Date:  2013-02-23

Review 3.  Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis.

Authors:  Lynn Soong; Calvin A Henard; Peter C Melby
Journal:  Semin Immunopathol       Date:  2012-10-11       Impact factor: 9.623

Review 4.  Effect of treating co-infections on HIV-1 viral load: a systematic review.

Authors:  Kayvon Modjarrad; Sten H Vermund
Journal:  Lancet Infect Dis       Date:  2010-07       Impact factor: 25.071

Review 5.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 6.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

7.  Dolabelladienetriol, a compound from Dictyota pfaffii algae, inhibits the infection by Leishmania amazonensis.

Authors:  Deivid Costa Soares; Teresa C Calegari-Silva; Ulisses G Lopes; Valéria L Teixeira; Izabel C N de Palmer Paixão; Claudio Cirne-Santos; Dumith Chequer Bou-Habib; Elvira M Saraiva
Journal:  PLoS Negl Trop Dis       Date:  2012-09-06

8.  Inhibition of HIV-1 replication in human monocyte-derived macrophages by parasite Trypanosoma cruzi.

Authors:  Guadalupe Andreani; Ana M Celentano; María E Solana; Silvia I Cazorla; Emilio L Malchiodi; Liliana A Martínez Peralta; Guillermina L Dolcini
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

9.  An in vitro co-infection model to study Plasmodium falciparum-HIV-1 interactions in human primary monocyte-derived immune cells.

Authors:  Guadalupe Andreani; Dominic Gagnon; Robert Lodge; Michel J Tremblay; Dave Richard
Journal:  J Vis Exp       Date:  2012-08-15       Impact factor: 1.355

10.  Arginase activity in the blood of patients with visceral leishmaniasis and HIV infection.

Authors:  Yegnasew Takele; Tamrat Abebe; Teklu Weldegebreal; Asrat Hailu; Workagegnehu Hailu; Zewdu Hurissa; Jemal Ali; Ermiyas Diro; Yifru Sisay; Tom Cloke; Manuel Modolell; Markus Munder; Fabienne Tacchini-Cottier; Ingrid Müller; Pascale Kropf
Journal:  PLoS Negl Trop Dis       Date:  2013-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.